Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index.

Anderson PG, Kalli S, Sassaroli A, Krishnamurthy N, Makim SS, Graham RA, Fantini S.

Acad Radiol. 2017 Oct;24(10):1240-1255. doi: 10.1016/j.acra.2017.03.020. Epub 2017 May 19.

PMID:
28532642
2.

Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy.

Ramirez G, Proctor AR, Jung KW, Wu TT, Han S, Adams RR, Ren J, Byun DK, Madden KS, Brown EB, Foster TH, Farzam P, Durduran T, Choe R.

Biomed Opt Express. 2016 Aug 24;7(9):3610-3630. eCollection 2016 Sep 1.

3.

Heterodyne frequency-domain multispectral diffuse optical tomography of breast cancer in the parallel-plane transmission geometry.

Ban HY, Schweiger M, Kavuri VC, Cochran JM, Xie L, Busch DR, Katrašnik J, Pathak S, Chung SH, Lee K, Choe R, Czerniecki BJ, Arridge SR, Yodh AG.

Med Phys. 2016 Jul;43(7):4383. doi: 10.1118/1.4953830.

4.

US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.

Kim MJ, Su MY, Yu HJ, Chen JH, Kim EK, Moon HJ, Choi JS.

BMC Cancer. 2016 Feb 1;16:50. doi: 10.1186/s12885-016-2086-7.

5.

Diffuse Optics for Tissue Monitoring and Tomography.

Durduran T, Choe R, Baker WB, Yodh AG.

Rep Prog Phys. 2010 Jul;73(7). pii: 076701.

6.

Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures.

Chung SH, Feldman MD, Martinez D, Kim H, Putt ME, Busch DR, Tchou J, Czerniecki BJ, Schnall MD, Rosen MA, DeMichele A, Yodh AG, Choe R.

Breast Cancer Res. 2015 May 27;17:72. doi: 10.1186/s13058-015-0578-z.

7.

Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress.

Xu C, Vavadi H, Merkulov A, Li H, Erfanzadeh M, Mostafa A, Gong Y, Salehi H, Tannenbaum S, Zhu Q.

Ultrason Imaging. 2016 Jan;38(1):5-18. doi: 10.1177/0161734615580280. Epub 2015 Apr 16.

8.

Broadband optical mammography: chromophore concentration and hemoglobin saturation contrast in breast cancer.

Anderson PG, Kainerstorfer JM, Sassaroli A, Krishnamurthy N, Homer MJ, Graham RA, Fantini S.

PLoS One. 2015 Mar 17;10(3):e0117322. doi: 10.1371/journal.pone.0117322. eCollection 2015.

9.

Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria.

Zhu Q, Wang L, Tannenbaum S, Ricci A Jr, DeFusco P, Hegde P.

Breast Cancer Res. 2014 Oct 28;16(5):456. doi: 10.1186/s13058-014-0456-0.

10.

Designing a wearable navigation system for image-guided cancer resection surgery.

Shao P, Ding H, Wang J, Liu P, Ling Q, Chen J, Xu J, Zhang S, Xu R.

Ann Biomed Eng. 2014 Nov;42(11):2228-37. doi: 10.1007/s10439-014-1062-0. Epub 2014 Jul 1.

11.

Optically measured microvascular blood flow contrast of malignant breast tumors.

Choe R, Putt ME, Carlile PM, Durduran T, Giammarco JM, Busch DR, Jung KW, Czerniecki BJ, Tchou J, Feldman MD, Mies C, Rosen MA, Schnall MD, DeMichele A, Yodh AG.

PLoS One. 2014 Jun 26;9(6):e99683. doi: 10.1371/journal.pone.0099683. eCollection 2014.

12.

Optical tecnology developments in biomedicine: history, current and future.

Nioka S, Chen Y.

Transl Med UniSa. 2011 Oct 17;1:51-150. Print 2011 Sep.

13.

Combined hemoglobin and fluorescence diffuse optical tomography for breast tumor diagnosis: a pilot study on time-domain methodology.

Zhang W, Wu L, Li J, Yi X, Wang X, Lu Y, Chen W, Zhou Z, Zhang L, Zhao H, Gao F.

Biomed Opt Express. 2013 Feb 1;4(2):331-48. doi: 10.1364/BOE.4.000331. Epub 2013 Jan 25.

14.

Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.

Choe R, Durduran T.

IEEE J Sel Top Quantum Electron. 2012 Jul;18(4):1367-1386. Epub 2011 Dec 2.

15.
16.

Diffuse optical imaging using spatially and temporally modulated light.

O'Sullivan TD, Cerussi AE, Cuccia DJ, Tromberg BJ.

J Biomed Opt. 2012 Jul;17(7):071311. doi: 10.1117/1.JBO.17.7.071311. Review.

17.
18.

Clustered targets imaged by optical tomography guided by ultrasound.

Xu Y, Xu C, Zhu Q.

J Biomed Opt. 2011 Jul;16(7):076018. doi: 10.1117/1.3600773.

19.

In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome.

Zhao D, Chang CH, Kim JG, Liu H, Mason RP.

Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):574-81. doi: 10.1016/j.ijrobp.2010.12.028. Epub 2011 Feb 23.

20.

Imaging heterogeneous absorption distribution of advanced breast cancer by optical tomography.

Xu Y, Zhu Q.

J Biomed Opt. 2010 Nov-Dec;15(6):066007. doi: 10.1117/1.3505015.

Supplemental Content

Support Center